BioCentury
ARTICLE | Company News

King to pull Theelin NDA

December 21, 2001 8:00 AM UTC

KG will withdraw its NDA for Theelin estrone injectable suspension to treat moderate to severe vasomotor symptoms of menopause and vaginal and vulvar atrophy. KG said the FDA requested additional clin...